Fifth Third Bancorp Boosts Stock Position in The Clorox Company (NYSE:CLX)

Fifth Third Bancorp grew its stake in shares of The Clorox Company (NYSE:CLX) by 3.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,519 shares of the company’s stock after purchasing an additional 168 shares during the quarter. Fifth Third Bancorp’s holdings in Clorox were worth $734,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Brooklyn Investment Group lifted its stake in Clorox by 163.8% in the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after buying an additional 95 shares during the last quarter. Prospera Private Wealth LLC purchased a new stake in Clorox in the 3rd quarter valued at approximately $27,000. Continuum Advisory LLC grew its holdings in Clorox by 300.0% during the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after acquiring an additional 138 shares during the period. Quarry LP grew its stake in shares of Clorox by 99.1% during the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock worth $31,000 after purchasing an additional 114 shares during the period. Finally, Carolina Wealth Advisors LLC acquired a new position in Clorox during the third quarter worth about $48,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Trading Down 1.0 %

Shares of CLX opened at $157.95 on Thursday. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37. The stock’s 50-day moving average is $163.36 and its two-hundred day moving average is $158.01. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. The stock has a market cap of $19.55 billion, a PE ratio of 55.04, a P/E/G ratio of 2.92 and a beta of 0.42.

Clorox (NYSE:CLX) last released its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, topping analysts’ consensus estimates of $1.36 by $0.50. The firm had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. Clorox’s quarterly revenue was up 27.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.49 EPS. Equities analysts forecast that The Clorox Company will post 6.87 earnings per share for the current fiscal year.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be given a $1.22 dividend. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a yield of 3.09%. Clorox’s payout ratio is currently 170.03%.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on the company. TD Cowen upgraded Clorox from a “sell” rating to a “hold” rating and raised their price target for the company from $155.00 to $170.00 in a research report on Wednesday, November 6th. Barclays reduced their price objective on shares of Clorox from $139.00 to $130.00 and set an “underweight” rating on the stock in a research note on Friday, January 17th. DA Davidson lifted their target price on shares of Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a research note on Monday, November 4th. StockNews.com lowered Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. Finally, JPMorgan Chase & Co. upped their target price on Clorox from $167.00 to $171.00 and gave the company a “neutral” rating in a research note on Thursday, January 16th. Four analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $156.54.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.